Marketing Effectiveness Archives - Return On Focus Return On Focus | https://returnonfocus.com | Return On Focus

What We Think

EVIDENCE bLOG

Majority of DTC Advertising Still Only Stimulates an ‘Inquiry’ NOT a Request – ROF Normative Update

DTC Advertising Actions

Back in 2010, I authored a blog post using the patient data that my then 4-year old company had amassed challenging the conventional wisdom that direct-to-consumer advertising (DTCA) is effective at activating a brand request by patients exposed to the advertising. Read On

Six Essential Elements of Successful Specialty Brand Support Services

Number SixIt seems like every new product launching today is a specialty pharmaceutical that requires access via a network of specialty pharmacies. This access system introduces a hurdle not only for the patient and prescriber, but also for the manufacturer – streamlining the process from prescription generation by the physician to medication acquisition by the patient. Read On

Why Rare Disease Patients/Caregivers Require More Manufacturer Support Than Cancer Patients?

An interesting question recently arose from our launch readiness work for a rare disease client. The question was “Do rare disease patients and caregivers really require more manufacturer support than cancer patients?” My immediate answer was “Yes”, which lead to some disbelieving faces. If you think about it, I understand the skepticism. For example:

Are rare disease patients sicker or do they fighter harder for their life than a cancer patient? – No.

Is it any harder for rare disease patients and caregivers to afford their care than cancer patients? – No, probably not.

Why then do I say that rare disease patients and caregivers require more manufacturer support? There were two main reasons supporting my belief. Read On

Follow us on
Pinterest Twitter slideshare
Contact Us
XXX

Powered by WordPress